Psychosis patients with lifetime exposure to antipsychotic medications often develop severe cardio-metabolic disorders and worsening cognitive impairments, therefore adjunct therapies that mitigate or attenuate these conditions would greatly enhance patient care. In recent years, the intestinal microbiome has emerged as an exciting area of research where gut microbial communities could influence cognitive and metabolic processes. However, experimental evidence of the molecular intera...